Tag Archives: Jayson Bedford

Analysts Offer Insights on Healthcare Companies: and AngioDynamics (NASDAQ: ANGO)

Analysts fell to the sidelines weighing in on and AngioDynamics (ANGO – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. AngioDynamics (ANGO) In a report issued on April 18, Jayson Bedford

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and Ionis Pharmaceuticals (NASDAQ: IONS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ – Research Report) and Ionis Pharmaceuticals (IONS – Research Report). Johnson & Johnson (JNJ) In a report issued on February 13,

Raymond James Keeps a Hold Rating on Integra Lifesciences (IART)

In a report released yesterday, Jayson Bedford from Raymond James maintained a Hold rating on Integra Lifesciences (IART – Research Report). The company’s shares closed last Tuesday at $46.42. According to TipRanks.com, Bedford is a 5-star analyst with an average

Raymond James Maintains Their Buy Rating on Merit Medical Systems (MMSI)

Raymond James analyst Jayson Bedford maintained a Buy rating on Merit Medical Systems (MMSI – Research Report) today. The company’s shares closed last Monday at $43.41. According to TipRanks.com, Bedford is a 5-star analyst with an average return of 15.7%

Natus Medical (NTUS) Gets a Hold Rating from Raymond James

Raymond James analyst Jayson Bedford maintained a Hold rating on Natus Medical (NTUS – Research Report) on October 17. The company’s shares closed last Wednesday at $18.15, close to its 52-week low of $16.62. According to TipRanks.com, Bedford is a

Raymond James Keeps a Hold Rating on Natus Medical (NTUS)

In a report released today, Jayson Bedford from Raymond James maintained a Hold rating on Natus Medical (NTUS – Research Report). The company’s shares closed last Wednesday at $18.15, close to its 52-week low of $16.62. According to TipRanks.com, Bedford